{"id":"adxs31-142","safety":{"commonSideEffects":[{"rate":"30%","effect":"Fatigue"},{"rate":"20%","effect":"Nausea"},{"rate":"15%","effect":"Diarrhea"}]},"_chembl":{"chemblId":"CHEMBL3663446","moleculeType":"Small molecule","molecularWeight":"407.45"},"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"ADXS31-142 is a live, attenuated Listeria monocytogenes-based immunotherapy that targets the MUC1 antigen, which is overexpressed in various cancers.","oneSentence":"Listeria monocytogenes-based immunotherapy targeting MUC1","_ai_confidence":"medium"},"_scrapedAt":"2026-03-28T05:50:06.367Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Non-small cell lung cancer"},{"name":"Ovarian cancer"}]},"trialDetails":[{"nctId":"NCT02325557","phase":"PHASE1, PHASE2","title":"ADXS31-142 Alone and in Combination With Pembrolizumab (MK-3475) in Participants With Previously Treated Metastatic Castration-Resistant Prostate Cancer (mCRPC)","status":"COMPLETED","sponsor":"Advaxis, Inc.","startDate":"2015-06-04","conditions":"Cancer, Prostate Cancer","enrollment":50}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":2,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_1","status":"active","brandName":"ADXS31-142","genericName":"ADXS31-142","companyName":"Advaxis, Inc.","companyId":"advaxis-inc","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Listeria monocytogenes-based immunotherapy targeting MUC1 Used for Non-small cell lung cancer, Ovarian cancer.","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":1,"withResults":1},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}